APTIMA HPV 16 18/45 Genotype Assay Approved by FDA
15 Oct 2012Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's APTIMA HPV 16 18/45 Genotype Assay for use on its TIGRIS instrument system.
Hologic's APTIMA HPV 16 18/45 Genotype Assay is the first test FDA-approved for genotyping human papillomavirus (HPV) types 16, 18 and/or 45, which are associated with approximately 80% of all invasive cervical cancers worldwide. Detecting these HPV types provides health care professionals with more information regarding a patient's risk of subsequently developing cervical cancer.
The APTIMA HPV 16 18/45 Genotype Assay is intended to test specimens from women with APTIMA HPV Assay positive results and is approved for two uses:
• Adjunctively with the APTIMA HPV Assay in women 30 years and older in combination with cervical cytology to assess the presence or absence of specific high-risk genotypes 16, 18 and/or 45.
• Adjunctively with the APTIMA HPV Assay in women 21 years or older with atypical squamous cells of undetermined significance (ASC-US) cervical cytology results to assess the presence or absence of specific high-risk HPV genotypes 16, 18 and/or 45. The results of this test are not intended to prevent women from proceeding to colposcopy.
"The introduction of the APTIMA HPV 16 18/45 Genotype Assay enhances our HPV product offering on the TIGRIS platform," said Rob Cascella, President and Chief Executive Officer of Hologic. "We are pleased to now offer the most comprehensive portfolio of products that address the cervical cancer screening market and we look forward to maintaining our leadership in this important field."
Related Products
Request Quote for All Products
ThinPrep 3000
Hologic, Inc.Improved productivity Dramatically reduces the time currently required to process the ThinPrep Pap Test: up to 80 samples per cycle. Walk away automation Processes the ThinPrep Pap Test samples unattended, allowing laboratory personnel to perform other duties. Chain-of-custody Maintains the security of patient samples through automatic chain-of-custody verification. Convenient storage and retrieval Easy storage and retrieval of sample vials after processing; facilitates reflex testing for sexually transmitted diseases. A simple four-step process 1. Load vial trays — vials are uncapped and recapped automatically 2. Load filter trays — utilizes ThinPrep processing technology 3. Load slide cartridges — processes 3 batches of 80 slides per 8-hour shift 4. Load staining racks — fully compatible with your laboratory's staining system Specifications of the ThinPrep 3000 Throughput: 3 batches of 80 slides per 8-hour shift. Up to 60,000 samples per year with a single 8-hour shift. Capacity: 80 sample vials (two 40-vial trays) per batch. 2 cartridges of 100 ThinPrep 3000 microscope slides. 2 trays of 100 ThinPrep 3000 filters. 4 slide staining racks of 20 slides each. Dimensions: 48" wide x 28" deep x 62" high 122 cm wide x 71 cm deep x 158 cm high